IL73568A - Yeast hybrid vector comprising the yeast pho5 promoter,a dna sequence encoding a signal peptide,the human tissue plaminogen activator coding region and a dna sequence encoding yeast transcription termination signals,a method for producing the vector,a yeast host transformed by the vector,a method for producing the transformed host,a method for producing biologically active human tissue plasminogen activator using a so transformed host and human tissue plasminogen activator produced by the method - Google Patents

Yeast hybrid vector comprising the yeast pho5 promoter,a dna sequence encoding a signal peptide,the human tissue plaminogen activator coding region and a dna sequence encoding yeast transcription termination signals,a method for producing the vector,a yeast host transformed by the vector,a method for producing the transformed host,a method for producing biologically active human tissue plasminogen activator using a so transformed host and human tissue plasminogen activator produced by the method

Info

Publication number
IL73568A
IL73568A IL73568A IL7356884A IL73568A IL 73568 A IL73568 A IL 73568A IL 73568 A IL73568 A IL 73568A IL 7356884 A IL7356884 A IL 7356884A IL 73568 A IL73568 A IL 73568A
Authority
IL
Israel
Prior art keywords
yeast
human tissue
producing
vector
sequence encoding
Prior art date
Application number
IL73568A
Other languages
English (en)
Other versions
IL73568A0 (en
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838331045A external-priority patent/GB8331045D0/en
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of IL73568A0 publication Critical patent/IL73568A0/xx
Publication of IL73568A publication Critical patent/IL73568A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • C12N15/69Increasing the copy number of the vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
IL73568A 1983-11-21 1984-11-20 Yeast hybrid vector comprising the yeast pho5 promoter,a dna sequence encoding a signal peptide,the human tissue plaminogen activator coding region and a dna sequence encoding yeast transcription termination signals,a method for producing the vector,a yeast host transformed by the vector,a method for producing the transformed host,a method for producing biologically active human tissue plasminogen activator using a so transformed host and human tissue plasminogen activator produced by the method IL73568A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838331045A GB8331045D0 (en) 1983-11-21 1983-11-21 Synthesis of fibrinolytic agents by yeast
GB848423112A GB8423112D0 (en) 1983-11-21 1984-09-13 Synthesis of fibrino lytic agents by yeast

Publications (2)

Publication Number Publication Date
IL73568A0 IL73568A0 (en) 1985-02-28
IL73568A true IL73568A (en) 1992-07-15

Family

ID=26287024

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73568A IL73568A (en) 1983-11-21 1984-11-20 Yeast hybrid vector comprising the yeast pho5 promoter,a dna sequence encoding a signal peptide,the human tissue plaminogen activator coding region and a dna sequence encoding yeast transcription termination signals,a method for producing the vector,a yeast host transformed by the vector,a method for producing the transformed host,a method for producing biologically active human tissue plasminogen activator using a so transformed host and human tissue plasminogen activator produced by the method

Country Status (17)

Country Link
EP (1) EP0143081B1 (fi)
JP (1) JPS6119489A (fi)
KR (1) KR930002889B1 (fi)
AU (1) AU595478B2 (fi)
DD (1) DD229151A5 (fi)
DE (1) DE3479520D1 (fi)
DK (1) DK164941C (fi)
ES (1) ES8609471A1 (fi)
FI (1) FI86746C (fi)
GR (1) GR80966B (fi)
HU (1) HU201115B (fi)
IE (1) IE57699B1 (fi)
IL (1) IL73568A (fi)
NO (1) NO844618L (fi)
NZ (1) NZ210266A (fi)
PH (1) PH22337A (fi)
PT (1) PT79518B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68366A (en) * 1982-04-15 1990-08-31 Genentech Inc Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
JPS61502655A (ja) * 1984-07-09 1986-11-20 インテグレ−テッド・ジェネティックス・インコ−ポレ−テッド 酵母クロ−ニングビヒクル
DK175327B1 (da) * 1984-10-01 2004-08-23 Integrated Genetics Inc Replicerbar ekspressionsvektor og rekombinant DNA-molekyle, som indkoder aktiv human livmodervævsplasminogen-aktivator, pattedyrscelle transformeret med vektoren og fremgangsmåde til fremstilling af aktiv human vævsplasminogen-aktivator (TPA)
JPS624233A (ja) * 1985-07-01 1987-01-10 Toyobo Co Ltd 組織性プラスミノ−ゲン活性化因子の製造法
JPS6229975A (ja) * 1985-08-01 1987-02-07 Mitsui Toatsu Chem Inc 粗tPAの精製法
GB8521496D0 (en) * 1985-08-29 1985-10-02 Ciba Geigy Ag Repressible yeast promoters
EP0216573B1 (en) * 1985-09-18 1990-11-22 Green Cross Corporation Yeast promoter and method of producing heterologous proteins
USH2055H1 (en) * 1985-09-20 2002-12-03 Zymogenetics, Inc. Expression of tissue-type plasminogen activator in bacteria
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
US5106741A (en) * 1985-12-20 1992-04-21 The Upjohn Company Tissue plasminogen activator (TPA) analogs
US4898825A (en) * 1986-05-07 1990-02-06 Mitsui Toatsu Chemicals, Incorporated Methods for purification of single-chain and double-chain tissue plasminogen activator
ZA872534B (en) * 1986-05-08 1987-11-25 Phillips Petroleum Co Yeast production of streptokinase
PT84991B (pt) * 1986-06-06 1990-03-08 Genentech Inc Processo para a producao de actividador do plasminogenio biologicamente activo
JPS6463378A (en) * 1986-08-11 1989-03-09 Mitsui Toatsu Chemicals Separation of single stranded tpa and double standard tpa
GB8621118D0 (en) * 1986-09-01 1986-10-08 Whitbread & Co Plc Stabilised polypeptides
EP0263072B1 (en) 1986-10-03 1994-03-23 Ciba-Geigy Ag Novel lymphokine related peptides
PT86162B (pt) * 1986-11-21 1990-11-20 Smithkline Beecham Corp Expressao de proteina recombinante
ZA879286B (en) 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5089409A (en) * 1989-09-28 1992-02-18 Monsanto Company Method of increasing specific activity of t-pa
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
SG49862A1 (en) * 1993-08-04 2002-03-19 Ucp Gen Pharma Ag High molecular weight desulphatohirudin
EP0801682B1 (en) 1995-02-09 2001-10-24 Novartis AG Process for the production of proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides
EP0174835A1 (en) * 1984-09-11 1986-03-19 The Upjohn Company Human tissue plasminogen activator and recombinant DNA compounds
DK175327B1 (da) * 1984-10-01 2004-08-23 Integrated Genetics Inc Replicerbar ekspressionsvektor og rekombinant DNA-molekyle, som indkoder aktiv human livmodervævsplasminogen-aktivator, pattedyrscelle transformeret med vektoren og fremgangsmåde til fremstilling af aktiv human vævsplasminogen-aktivator (TPA)

Also Published As

Publication number Publication date
KR930002889B1 (ko) 1993-04-12
IE842965L (en) 1985-05-21
HUT36185A (en) 1985-08-28
DK551084D0 (da) 1984-11-20
AU3571984A (en) 1986-03-20
ES537828A0 (es) 1986-07-16
DK164941B (da) 1992-09-14
PT79518B (pt) 1986-12-12
EP0143081B1 (en) 1989-08-23
IL73568A0 (en) 1985-02-28
NO844618L (no) 1985-05-22
FI844544A0 (fi) 1984-11-19
KR850003733A (ko) 1985-06-26
NZ210266A (en) 1988-11-29
AU595478B2 (en) 1990-04-05
DK551084A (da) 1985-05-22
JPS6119489A (ja) 1986-01-28
FI86746B (fi) 1992-06-30
ES8609471A1 (es) 1986-07-16
EP0143081A3 (en) 1987-01-07
IE57699B1 (en) 1993-03-10
PT79518A (en) 1984-12-01
HU201115B (en) 1990-09-28
FI844544L (fi) 1985-05-22
EP0143081A2 (en) 1985-05-29
GR80966B (en) 1985-03-15
FI86746C (fi) 1992-10-12
DE3479520D1 (en) 1989-09-28
DD229151A5 (de) 1985-10-30
PH22337A (en) 1988-08-12
DK164941C (da) 1993-02-01

Similar Documents

Publication Publication Date Title
IL73568A (en) Yeast hybrid vector comprising the yeast pho5 promoter,a dna sequence encoding a signal peptide,the human tissue plaminogen activator coding region and a dna sequence encoding yeast transcription termination signals,a method for producing the vector,a yeast host transformed by the vector,a method for producing the transformed host,a method for producing biologically active human tissue plasminogen activator using a so transformed host and human tissue plasminogen activator produced by the method
EP0853121A3 (en) Human DNase
IE842881L (en) Atrial peptides
ZA857574B (en) Human uterine tissue plasminogen activator produced by recombinant dna
IL94128A (en) Nucleic acids encoding vascular endothelial cell growth factors, expression vectors and host cells comprising such nucleic acids and methods of producing such vascular endothelial growth factors
ES2009907A6 (es) Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida.
MY101203A (en) Production of thrombin iinhibitors.
AU3802595A (en) Tripeptidyl aminopeptidase
AU3707284A (en) Fibrinolytic enzyme blocked by human protein
AU680816B2 (en) Cloning and expression of DNA encoding a ripening form of a polypeptide having phamnogalacturonase activity
AU2913589A (en) Method to solubilize tissue plasminogen activator
AU3346289A (en) Heparin-binding proteins, DNA coding for them, processes for producing them as well as therapeutic preparations containing them
WO1994012648A3 (fr) Production de sous-unites de recepteurs t solubles par co-transfection, utilisations des produits ainsi obtenus
AU2085195A (en) Gene coding for igg-fc-binding protein
ES8506194A1 (es) Polipeptido de interferon- humano
IL84702A (en) Expression vectors for expression of a protein in higher eukaryotic host cells comprising an enhancer/promoter unit, a protein encoding sequence, signal sequences, and selection marker gene, host cells transformed thereby, a method for producing the protein using the transformed host cells and host cells transformed by the vectors for cloning and multiplication of the vectors
AU3838189A (en) Tissue plasminogen activator analogues having improved activity
HUT47976A (en) Process for producing recombinant expression dna vectors encoding isopenicillin-n-synthetase enzyme of aspergillus nidulans, as well as dna molecules
ES8504248A1 (es) Procedimiento para la fabricacion de un plasmido recombinante que contiene un aminoacido
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
EP0339505A3 (en) Monoclonal antibodies to tissue plasminogen activator (t-pa) which prolong its functional half-life
IL89391A0 (en) Structural gene coding for an insecticidal endotoxin protein,said protein,its production and use of said gene and protein
EP0146903A3 (en) Production of a vector encoding a novel hybrid interferon species
AU1999488A (en) A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein
PT82311A (en) Method for producing recombinant human renin